Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
